Skip to content
SEMICAL logo — SEMICAL is a company specializing in the development of inno...

SEMICAL

SEMICAL is a company specializing in the development of innovative biomaterials for hard and soft tissue repair.

Founded 2018 Turkey Turkey 32 employees Biotechnology, Life Sciences

General Information

Company Name SEMICAL
Founded Year 2018
Location Turkey Turkey
Employees 32
Industries Biotechnology, Life Sciences
Social

BounceWatch is an independent company data service, not affiliated with SEMICAL. To contact SEMICAL, visit semical.com.tr.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does SEMICAL compare?

A PDF of SEMICAL and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting SEMICAL soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About SEMICAL

Semical is a biotechnology startup founded in 2018, headquartered in Turkey. Specialized in innovative biomaterials for both hard and soft tissue repair, the company endeavors to meet market demands with high-quality products and introduce technological advancements for surgical specialists. Boasting a robust R&D infrastructure, Semical offers technology transfer services globally in the pharmaceuticals and medical devices sector, handling everything from product development to turnkey projects. Their scope extends to biosurgery and dermocosmetic product groups. The company, led by a team of expert academicians, carves a niche in hemostasis, adhesion prevention, osteoarthritis, tissue adhesives, bone grafts, aortic stents, dental implants, dental grafts, and dermocosmetics.

Business keywords: biomaterials, R&D infrastructure, pharmaceuticals, biosurgery, dermocosmetic, regenerative medicine, hemostasis, adhesion prevention, osteoarthritis, tissue adhesives, bone grafts, aortic stents, dental implants, dental grafts

No funding data available for SEMICAL yet.

SEMICAL Alternatives & Competitors

View All Alternatives
SEMICAL vs

Global Leader in Synthetic & Resorbable Biomaterials

47 employees
Biotechnology, Digital Health
SEMICAL vs

From replacement to regeneration

11 employees
Biotechnology, Health Care
SEMICAL vs

Tissue regeneration via gene therapy

Grant
2 employees
Biotechnology, Health Care

FAQ About SEMICAL

SEMICAL is a company specializing in the development of innovative biomaterials for hard and soft tissue repair.
SEMICAL was founded in 2018.
SEMICAL is headquartered in Turkey.
SEMICAL operates in Biotechnology and Life Sciences. Its work centres on biomaterials, R&D infrastructure, pharmaceuticals and biosurgery.
SEMICAL has approximately 32 employees.
Top alternatives and competitors to SEMICAL include Bonegraft Biomaterials, osteobionix, TherageniX. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SEMICAL and Bonegraft Biomaterials are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SEMICAL, https://bouncewatch.com/company/semical, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout